Clinical Trial Update: Trial of Dasatinib in Advanced Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 trial update for dasatinib in advanced sarcomas, with completed status and results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chondrosarcoma
• Chordoma
• Epithelioid Sarcoma
• Giant Cell Tumor of Bone
• Malignant Peripheral Nerve Sheath Tumors
• Rhabdomyosarcoma
• Sarcoma Alveolar Soft Part
• Sarcoma Ewing

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

Sponsor: Sarcoma Alliance for Research through Collaboration | Conditions: Rhabdomyosarcoma, Malignant Peripheral Nerve Sheath Tumors | Phase 2 | Status: COMPLETED | Results posted: 2018-11-23